Posted October 14, 2015

Corey Casper, M.D., M.P.H

Posted October 14, 2015

Charles G. Mullighan, MBBS (Hons), MSC, MD

Posted October 14, 2015

Ariela Noy, MD

Posted October 2, 2015

Sam Mbulaiteye, M.D.

Sam Mbulaiteye is a Senior Investigator at the Infections and Immunoepidemiology Branch at the National Cancer Institute at the National Institutes of Health.  Trained as a specialist in internal medicine at Makerere University, Uganda and as an epidemiologist at the University of Cambr…

Posted October 2, 2015

Jeremy Abramson, MD

Dr. Abramson is Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center.  He is also Assistant Professor of Medicine at Harvard Medical School.  He earned his medical degree from the Mount Sinai School of …

Posted October 26, 2020

Alina Gerrie, M.D., MPH, FRCPC

Dr. Alina Gerrie is Assistant Professor of Medicine at the University of British Columbia in Vancouver, Canada. She is a Hematologist and member of the Lymphoma Tumour Group at BC Cancer and a Clinician Investigator with the Centre for Lymphoid Cancer at the BC Cancer Research Centre. Dr. Ge…

Posted October 26, 2020

David Scott, MBChB, PhD, FRACP, FRCPA

Dr. David Scott, is an Associate Professor in the Department of Medicine at the University of British Columbia and a Scientist in the Department of Lymphoid Cancer Research (BC Cancer).  He gained his MBChB, PhD from the University of Auckland, New Zealand.  Following his clinical …

Posted October 2, 2015

Wyndham H. Wilson, M.D., Ph.D.

Wyndham H. Wilson is Head, Lymphoma Therapeutics Section and Senior Investigator of the Lymphoid Malignancy Branch, Center for Cancer Research at the National Cancer Institute.  He received his Ph.D. and M.D. at Stanford University and Stanford School of Medicine, respectively; and his …